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Background: Increased levels of myeloperoxidase (MPO) and micropaticles (MP)are known to be associated with a high risk and progression of 
acute coronary syndrome (ACS) and related disorders. Both of these mediators enhance athero-thrombogenesis. However, the association of these 
mediators to thrombin generation is not established. The purpose of this study was to determine the levels of MPO, MP and thrombin generation in 
baseline plasma samples (n=200) of patients undergoing percutaneous coronary angioplasty (PTCA).
Methods: Plasma samples from patients undergoing elective PTCA were collected at baseline. Control plasma samples were collected from 100 
normal individuals. These samples were analyzed for MPO utilizing an ELISA method (Enzo Life Sciences, Plymouth Meeting, PA), functional MP using 
a chromogenic substrate/Annexin trapping assay (Hyphen Biomedical, Paris, France) and thrombin generation employing a tissue factor activated 
flourogenic assay (Technoclone, Vienna, Austria).
Results: MPO levels were markedly elevated in ACS (36.7+24.1; range 0.4-74.8 ng/ml) in comparison to normals (7.7+2.4; range 0.3-12.6 ng/
ml). MP levels were also higher in the ACS group (21.6+6.1; range 3.1-32 nM) in contrast to normals (6.1+2.3; range 2.1-11.8 nM). Thrombin 
generation potential was significantly higher in the ACS group (668+120 nM; range 340-1160 nM) in comparison to normals (450+78 nM; range 
370-760 nM). Other thrombin generation markers such as the fibrinopeptide A, prothrombin fragment 1.2 and thrombin antithrombin complex were 
also higher in the ACS as compared to normals. There was no correlation between MPO and thrombin generation (r2 = .23). MP levels correlated well 
with thrombin generation (r2=.78).
Conclusions: Simultaneous increase in the MPO and MP levels promotes thrombogenesis in the ACS patients. New anticoagulants, in particular, 
the oral factor Xa inhibitors such as Rivaroxiban by virtue of their strong thrombin generation inhibitory potential, may be useful in the long term 
treatment of ACS associated procoagulant state.
